Drug Profile
Research programme: viral vaccines - Arbovax
Alternative Names: Tetravalent Dengue vaccine - ArbovaxLatest Information Update: 28 Oct 2016
Price :
$50
*
At a glance
- Originator Arbovax
- Class Antivirals; Vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Chikungunya virus infections; Dengue; West Nile virus infections
Most Recent Events
- 28 Oct 2016 No development reported - Preclinical for Chikungunya virus infections (Prevention) in USA (Parenteral)
- 28 Oct 2016 No development reported - Preclinical for Dengue (Prevention) in USA (Parenteral)
- 28 Oct 2016 No development reported - Preclinical for West Nile virus infections (Prevention) in USA (Parenteral)